Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

3.490

+0.030 (0.87%)

Oct 26, 2026, 9:46 AM EDT - Market open

Ironwood Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	577	548	709	1,786	1,901	1,908
Market Cap Growth	126.15%	-22.67%	-60.31%	-6.02%	-0.40%	4.64%
Enterprise Value	894	1,006	1,236	2,414	1,742	1,804
Last Close Price	3.46	3.37	4.43	11.44	12.39	11.66

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	4.42	22.83	805.60	-	10.86	3.61
Forward PE	2.80	7.84	13.42	14.14	11.24	8.43
PS Ratio	1.47	1.85	2.02	4.03	4.63	4.61
PB Ratio	-	-2.09	-2.35	-5.16	2.91	3.15
P/TBV Ratio	-	-	-	-	2.91	3.15
P/FCF Ratio	3.08	4.32	6.86	9.75	6.95	7.29
P/OCF Ratio	3.08	4.32	6.85	9.74	6.94	7.29
PEG Ratio	-	1.04	1.04	1.41	2.25	1.21

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.28	3.40	3.52	5.45	4.24	4.36
EV/EBITDA Ratio	3.74	8.33	12.56	12.23	6.92	7.72
EV/EBIT Ratio	3.76	8.46	12.82	12.33	6.96	7.77
EV/FCF Ratio	4.79	7.92	11.95	13.18	6.37	6.90

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-2.45	-2.28	-1.99	-2.07	0.64	0.79
Debt / EBITDA Ratio	1.65	4.83	5.85	3.56	1.63	2.01
Debt / FCF Ratio	2.14	4.71	5.80	3.91	1.52	1.82
Net Debt / Equity Ratio	-1.96	-1.46	-1.70	-1.80	-0.37	-0.24
Net Debt / EBITDA Ratio	1.33	3.16	5.19	3.16	-0.95	-0.62
Net Debt / FCF Ratio	1.71	3.01	4.94	3.40	-0.88	-0.55
Asset Turnover	1.24	0.79	0.86	0.56	0.37	0.49
Quick Ratio	5.84	1.08	4.39	0.80	30.23	4.54
Current Ratio	6.06	1.13	4.70	0.85	30.58	4.61
Return on Equity (ROE)	-	-	-	-674.04%	27.83%	158.09%
Return on Assets (ROA)	47.02%	19.88%	14.65%	15.58%	14.05%	17.21%
Return on Invested Capital (ROIC)	65.68%	17.48%	0.51%	64.52%	39.75%	75.47%
Return on Capital Employed (ROCE)	93.70%	76.90%	30.90%	100.40%	23.30%	24.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	22.61%	4.38%	0.12%	-56.11%	9.21%	27.69%
FCF Yield	32.45%	23.17%	14.59%	10.25%	14.40%	13.71%
Buyback Yield / Dilution	-3.27%	-1.81%	-2.99%	16.57%	-13.32%	-2.34%

SEC Filings: 10-K · 10-Q